(This note is not part of the Order)
This Order revokes the Export Control (Amendment) (No.3) Order 2010 (S.I. 2010/2843) which amended the Export Control Order 2008 (S.I. 2008/3231) (the “2008 Order”) to insert article 4A controlling the export of pharmaceutical goods containing sodium thiopental to the United States of America.
This Order inserts a new article 4A into the 2008 Order to prohibit the export of human and veterinary medicinal products containing sodium thiopental, pancuronium bromide, potassium chloride concentrate or sodium pentobarbital. The prohibition only applies to the export of these products where they are in a form suitable for injection or for preparation of an injection and the final destination is the United States of America.
Article 1(3) provides that this Order will cease to have effect on 13th April 2012.
A regulatory impact assessment has not been prepared for this instrument as it has no or minimal impact on business, charities or voluntary bodies. An Explanatory Memorandum is published alongside the instrument on www.legislation.gov.uk.